N17001

Noggin human

recombinant, expressed in HEK 293 cells, suitable for cell culture

Manufacturer: Sigma Aldrich

Synonym(S): Noggin human

Select a Size

Pack Size SKU Availability Price
20 μG N17001-20-μG In Stock ₹ 41,187.20

N17001 - 20 μG

₹ 41,187.20

In Stock

Quantity

1

Base Price: ₹ 41,187.20

GST (18%): ₹ 7,413.696

Total Price: ₹ 48,600.896

recombinant

expressed in HEK 293 cells

Quality Level

200

Assay

≥98% (SDS-PAGE)

form

lyophilized powder

potency

≤10 ng/mL ED50

mol wt

23 kDa (The protein migrates as a 25 kDa band on SDS-PAGE due to glycosylation)

technique(s)

cell culture | mammalian: suitable

storage temp.

−20°C

Related Products

Img

Sigma Aldrich

ECM002

recombinant, expressed in HEK 293 c...

Img

Sigma Aldrich

I17001

IFN-gamma, recombinant, expressed i...

Img

Sigma Aldrich

E5546

recombinant, expressed in HEK 293 c...

Description

  • General description: Recombinant human Noggin is expressed in human 293 cells as a glycoprotein with a calculated molecular mass of 23 kDa. This protein is manufactured in human cells using an all-human production system, with no serum. The human cells expression system allows human-like glycosylation and folding, and often supports better stability of the protein in culture.
  • Biochem/physiol Actions: Noggin is a secreted protein that inhibits the binding of bone morphogenetic proteins (BMPs) to their cognate receptor. It is a 232 amino acid-secreted glycosylated protein, which forms covalently linked homodimers and has high affinity for BMP4.[1] hESC cultured with noggin (in medium or incorporated into extracellular matrix) form denser colonies compared to normal hESC cultures, suggesting that the presence of noggin promotes better growth. Noggin can be incorporated as a medium supplement for maintaining stem cells in a pluripotent state, for short-term culture experiments. Noggin does not trigger differentiation towards a neuronal lineage. Furthermore, when incorporated into extracellular matrix, noggin prevented spontaneous differentiation during the time period examined. In a surgically induced knee osteoarthritis model in mice, expression of noggin mRNA was lost from the articular cartilage, which correlated with loss of BMP2/4 and pSMAD1/5/8, an indicator of active BMP signaling.
  • Sequence: QHYLHIRPAPSDNLPLVDLIEHPDPIFDPKEKDLNETLLRSLLGGHYDPGFMATSPPEDRPGGGGGAAGGAEDLAELDQLLRQRPSGAMPSEIKGLEFSEGLAQGKKQRLSKKLRRKLQMWLWSQTFCPVLYAWNDLGSRFWPRYVKVGSCFSKRSCSVPEGMVCKPSKSVHLTVLRWRCQRRGGQRCGWIPIQYPIISECKCSC
  • Physical form: Supplied as a lyophilized powder containing phosphate buffered saline.
  • Analysis Note: The biological activity of recombinant human noggin was tested in culture by measuring its ability to inhibit BMP4-induced alkaline phosphatase production by ATDC5 cells (human erythroleukemic indicator cell line).The EC50 is defined as the effective concentration of growth factor that elicits a 50% decrease in alkaline phosphatase secretion in a cell based bioassay.

SAFETY INFORMATION

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Compare Similar Items

Show Difference

Img

Sigma Aldrich

N17001

recombinant, expressed in HEK 293 c...


recombinant:
expressed in HEK 293 cells

Quality Level:
200

Assay:
≥98% (SDS-PAGE)

form:
lyophilized powder

potency:
≤10 ng/mL ED50

mol wt:
23 kDa (The protein migrates as a 25 kDa band on SDS-PAGE due to glycosylation)

technique(s):
cell culture | mammalian: suitable

storage temp.:
−20°C

Img

Novus Biologicals

N172027APC7

--


recombinant:
__

Quality Level:
__

Assay:
__

form:
__

potency:
__

mol wt:
__

technique(s):
__

storage temp.:
__

Img

Novus Biologicals

N172027PEC5

--


recombinant:
__

Quality Level:
__

Assay:
__

form:
__

potency:
__

mol wt:
__

technique(s):
__

storage temp.:
__

Img

Novus Biologicals

N172027PEC7

--


recombinant:
__

Quality Level:
__

Assay:
__

form:
__

potency:
__

mol wt:
__

technique(s):
__

storage temp.:
__